openPR Logo
Press release

Present Scenario and Growth Prospects of Next Generation Sequencing Market Over The Period 2019 – 2026 | Illumina, Thermo Fisher Scientific, Pacific Biosciences of California, Qiagen NV, Beijing Genomics Institute

05-13-2019 07:37 PM CET | Health & Medicine

Press release from: Market Prognosis

Next Generation Sequencing Market

Next Generation Sequencing Market

Marketprognosis.com Publish a New Market Research Report On “Next Generation Sequencing - Global Market Outlook (2017-2026)” which contains global key player’s survey information and forecast to 2026.

Overview of the Global Next Generation Sequencing Market:

The Global Next Generation Sequencing Market is expected to grow at a CAGR of 18.7% during the forecast period.

The major key factors such as growing adoption of sequencing technologies in clinical applications and low cost DNA sequencing are likely to drive the market growth. On the other side, accuracy and standardization issues and lack of skilled labour are inhibiting the market growth. However, rise in personalize medicine and cloud computing are likely to create more opportunities for this market during the forecast period.

Get a Sample Copy of this Report @ https://marketprognosis.com/sample-request/16638 .

Next-generation sequencing enables rapid sequencing and produces millions of DNA and RNA sequences. It is otherwise called as massively parallel sequencing technology used in personalized medicines, clinical applications, animal research and other applications.

Depending upon the End Users, the Genetic Screening is a method used to provide important information on gene function as well as the molecular events that underlie a biological process or pathway or identify and select for individuals who possess a phenotype of interest in a mutagenized population. It totally depends on the accuracy of the test, the reliability of the interpretation of the results and the ability to treat the condition based on the quality. Apart from these, it can lessen the anxiety of not knowing the possibility of developing a disease and give a tremendous sense of relief.

Geographically, North America is expected to surpass the other regions throughout the forecast period due to the support from various government bodies, like NHGRI (National Human Genome Research Institute, US) and fund research on the genome's structure, function, and role in health and disease.

Purchase this report online with Top Key Players Analysis and List of Tables & Figure @ https://marketprognosis.com/buyReport/16638 .

Major Key Players:

1 Illumina, Inc.

2 Thermo Fisher Scientific Inc.

3 Pacific Biosciences of California, Inc.

4 Qiagen N.V.

5 Beijing Genomics Institute

6 Perkinelmer, Inc.

7 F. Hoffmann-La Roche AG

8 Agilent Technologies, Inc. and More……………

Market Segment by Products:

1 Instruments

2 Reagents & Consumables

3 Services

4 Platforms

Request a Discount on standard prices of this premium report @ https://marketprognosis.com/discount-request/16638 .

In the end, this report covers data and information on capacity and production overview, production, market share analysis, sales overview, supply, sales, and shortage, import, export and consumption as well as cost, price, revenue and gross margin of Next Generation Sequencing Market.

Table of Contents:

1 Executive Summary

2 Preface

3 Market Trend Analysis

4 Porters Five Force Analysis

5 Global Next-Generation Sequencing Market, By Type of Sequencing

6 Global Next-Generation Sequencing Market, By Product

7 Global Next-Generation Sequencing Market, By Application

8 Global Next-Generation Sequencing Market, By End User

9 Global Next-Generation Sequencing Market, By Geography

10 Key Developments

11 Company Profiling

About us:

We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:

ProgMark Pvt. Ltd.

Thane – 421501

India.

sales@marketprognosis.com

+1 973 241 5193

https://www.marketprognosis.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Present Scenario and Growth Prospects of Next Generation Sequencing Market Over The Period 2019 – 2026 | Illumina, Thermo Fisher Scientific, Pacific Biosciences of California, Qiagen NV, Beijing Genomics Institute here

News-ID: 1737384 • Views: 2534

More Releases from Market Prognosis

Technological Advancement in Global Mobile Advertising Market Forecast to 2026 …
Global Mobile Advertising Market Report 2019 offers elaborated knowledge on the market parts like size, Key Regions, growth, trends, dominating firms, Major Manufactures. The Mobile Advertising report introduces market competition situation among the vendors, revenue, product & services, latest developments and business strategies. Overview of the Global Mobile Advertising Market: The Global Mobile Advertising Market is accounted for $30.98 Billion in 2017 and is expected to reach $214.75 Billion by 2026 growing
Mining Chemicals Market Analysis and Forecast Report 2019 - 2026 with Estimated …
Global Mining Chemicals Market research report 2019 - 2026 provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. Overview of the Global Mining Chemicals Market: The Global Mining Chemicals Market is accounted for $6.11 Billion in 2017 and is expected to reach $10.01 Billion by 2026 growing at a CAGR of 5.6%. Significant factors which are influencing the market
Implantable Biomaterials Market Covering Prime Factors and Competitive Outlook T …
This comprehensive Implantable Biomaterials Market research report 2019 – 2026 includes a brief on these trends that can help the businesses operating in the industry to understand the market and strategize for their business expansion accordingly. The research report analyzes the market size, industry share, growth, key segments, CAGR and key drivers. Overview of the Global Implantable Biomaterials Market: The Global Implantable Biomaterials Market is accounted for $96.11 Billion in 2017 and
Booming Growth in Global Semi-Trailer Market and Forecast to 2023 by Worldwide T …
The report covers a forecast and an analysis of the Semi-Trailer Market on a global and regional level. The study provides historical data for 2016, 2017, and 2018 along with a forecast from 2019 to 2023 based on revenue and volume. Overview of the Global Semi-Trailer Market: The report spread across 89 pages is an overview of the Global Semi-Trailer Market - Analysis of Growth, Trends and Forecasts (2018 - 2023). These

All 5 Releases


More Releases for Sequencing

Precision Medicine Market Report 2018: Segmentation by Technology (Genomics, Tra …
Global Precision Medicine market research report provides company profile for Abbott Laboratories, Almac Group, Ltd, Asuragen, Inc., Cepheid Inc, Cetics Healthcare Technologies GmbH, Ge Healthcare, Glaxosmithkline Plc, Intomics A/S., Biocrates Life Sciences Ag, Pfizer Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Next Wave in DNA Sequencing Market
Sequencing by synthesis (SBS), is one of the most influential and greatly adopted DNA sequencing technologies used by researchers and scientist globally. This technology offers a massive sequence throughput at modest costs in a single sequencing run. DNA Sequencing Market was valued at $5,156 million in 2016 and is expected to reach $18,284 million in 2023, registering a CAGR of 19.6% from 2017 to 2023. DNA sequencing is a technology in
Next Generation Sequencing Market Global Analysis and Forecasts by Service (Geno …
ReportsWeb.com has announced the addition of the “Next Generation Sequencing Market to 2025”, the report classifies the global Next Generation Sequencing Market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth. The next generation market is estimated to account for US$ 26,501.2 Mn by the end of 2025, escalating at a CAGR of 21.1% during the
Next Generation Sequencing Market By Key Manufacturers (Illumina, Qiagen, Perkin …
Next generation sequencing (NGS) is the technology which is used to align millions of small fragments of DNA simultaneously that are capable of processing multiple DNA sequences in parallel. The arrival of rapid DNA sequencing methods has significantly enhanced biological and medical research and discovery. The next generation sequencing market is anticipated to grow at a CAGR of 21.1% and reach US$ 26.5Bn by 2025. Increasing application of NGS in clinical
Pyro Sequencing Market: Business Intelligence & Market Insights
Pyro sequencing is a DNA sequencing technology based on the principle of sequencing-by-synthesis. The method consist of series of four enzymatic steps to detect sequence of nuclei acid during synthesis. Pyro sequencing can be easily automated and provides highly accurate results. The method is highly suitable for analysis of single nucleotide polymorphism and sequencing of small fragment of DNA. Pyro sequencing techniques consist of series of sequential steps for detection
Next-generation Sequencing Market
Next-generation sequencing or high throughput sequencing are advanced DNA sequencing technologies, including Illumina (Solexa) sequencing, Roche 454 sequencing, and Ion torrent: Proton/ PGM sequencing, SOLiD sequencing. Next-generation sequencing technologies have a number of advantages such as high speed, flexibility, high throughput, and reduced sequencing cost. Next-generation sequencing has ability to produce terabytes of nucleotide sequence data in a lone sequencing procedure. The NGS technology is developing at a rapid rate,